Citations

Clear

4847 citation(s) found for "Yu, Eric".

Splenic Rupture as the First Manifestation of Babesia Microti Infection: Report of a Case and Review of Literature
Dumic, Igor , Patel, Janki, Hart, Melissa, Niendorf, Eric, Martin, Scott, Ramanan, Poornima , Niendorf, Eric R, Dumic, Igor

Mayo Clinic

American Journal of Case Reports | March 23, 2018 | Volume: 19 | Issue: No issue available | Pages: 335-341

10.12659/ajcr.908453 | PMID 29567936 Get It

Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology
Vidal, Claudia I. , Armbrect, Eric A., Andea, Aleodor A. , Bohlke, Angela, Comfere, Nneka I. , Hughes, Sarah , Kim, Jinah , Kozel, Jessica A. , Lee, Jason B. , Linos, Konstantinos , Litzner, Brandon R. , Missall, Tricia A. , Sundram, Uma , Swick, Brian L. , Hurley, M. Yadira , Alam, Murad , Argényi, Zsolt B., Duncan, Lyn M., Elston, Dirk M. , Emanuel, Patrick O. , Ferringer, Tammie , Fung, Maxwell A. , Hosler, Gregory A. , Lazar, Alexander J. , Prieto, Víctor G. , Schaffer, András , Subtil, Antonio , Wang, Wei‐Lien , Sundram, Uma , Hurley, Maria Yadira , Emanuel, Patrick O , Fung, Maxwell A , Hosler, Gregory A , Lazar, Alexander J , Vidal, Claudia I , Kim, Jinah , Linos, Konstantinos , Missall, Tricia A , Novoa, Roberto A. , Alam, Murad , Lowe, Lori , Plaza, Jose Antonio , Robinson, June K.

Mayo Clinic

Journal of Cutaneous Pathology | March 22, 2018 | Volume: 45 | Issue: 8 | Pages: 563-580

10.1111/cup.13142 | PMID 29566273 Get It

BackgroundAppropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy and physician decision‐making.ObjectivesThe American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology.MethodsThe RAND/UCLA appropriateness methodology, which combines evidence‐based medicine, clinical experience and expert judgment, was used to develop AUC in dermatopathology.ResultsWith the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89%) clinical scenarios, with 93 (44%) considered “usually appropriate,” 52 (25%) “rarely appropriate” and 43 (20%) “uncertain appropriateness.”LimitationsThe methodology requires a focus on appropriateness without comparison between tests and irrespective of cost.ConclusionsThe ultimate decision of when to order specific test rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness—AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed “uncertain appropriateness” and where consensus was not reached may benefit from further research.
Networking Matters: A Social Network Analysis of the Association of Program Directors of Internal Medicine
Warm, Eric J. , Arora, Vineet M. , Chaudhry, Saima , Halvorsen, Andrew J. , Schauer, Daniel P. , Thomas, Kris G., McDonald, Furman S., Warm, Eric , Halvorsen, Andrew, Thomas, Kris

Mayo Clinic

Teaching and Learning in Medicine | March 22, 2018 | Volume: 30 | Issue: 4 | Pages: 415-422

10.1080/10401334.2018.1441715 | PMID 29565686 Get It

FUNCTIONAL AND KINEMATIC ANALYSIS OF A WRIST RADIAL HEMIARTHROPLASTY DESIGN
Hooke, Alexander W. , Wagner, Eric R. , Pettersson, Kurt, Fischer, Per , Rizzo, Marco , Wagner, Eric R

Mayo Clinic

Journal of Musculoskeletal Research | March 22, 2018 | Volume: 21 | Issue: 01 | Pages: 1850005

10.1142/s0218957718500057 Get It

Purpose: A biomechanical functional assessment was performed on a newly designed wrist hemiarthroplasty implant with aimed to identifying differences between the native wrist and wrist following the hemiarthroplasty procedure with [Formula: see text] and without a proximal row carpectomy (Hemi). Methods: Six cadaveric wrists were mounted on a custom testing fixture and underwent a series of functional tests to investigate differences in range of motion, muscles moment arms, and axis of rotation between the intact and post-operative wrists. The tested movements included manually-driven flexion-extension, radial-ulnar deviation, dart throwers motion, and circumduction. Results: The only significant change in range of motion was a decrease in flexion between the intact [Formula: see text] and both the Hemi [Formula: see text] and [Formula: see text] [Formula: see text] conditions. Minor differences in the mean position and variability of the axis of rotation’s piercing point were identified. A statistically significant decrease in the flexion moment arm of the flexor carpi radialis was identified between the intact ([Formula: see text][Formula: see text]mm) and [Formula: see text] ([Formula: see text][Formula: see text]mm) conditions. Statistically significant decreases were also identified in the radial deviation moment arms of the extensor carpi radialis brevis’ between the intact ([Formula: see text][Formula: see text]mm) and [Formula: see text] ([Formula: see text][Formula: see text]mm) conditions and the flexor carpi radialis’ between the intact ([Formula: see text][Formula: see text]mm) and Hemi ([Formula: see text][Formula: see text]mm) conditions as well as in the ulnar deviation moment arm of the extensor carpi ulnaris between the intact ([Formula: see text][Formula: see text]mm) and Hemi ([Formula: see text][Formula: see text]mm) conditions. Conclusions: While some statistically significant functional changes were identified between the native and hemiarthroplasty wrist, the findings suggest that post-operative function is equally acceptable in hemiarthroplasty with and without resection of the proximal carpal row.
Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome
Thouvenot, Éric , Hinsinger, Geoffrey, Dematteï, Christophe , Uygunoğlu, Uğur , Castelnovo, Giovanni, Pittion‐Vouyovitch, S., Okuda, Darin T. , Kantarci, Orhun H. , Pelletier, Daniel , Lehmann, Sylvain , Marin, Philippe , Sıva, Aksel , Lebrun‐Frénay, Christine , Lebrun‐Frénay, Christine , Siva, Aksel , Thouvenot, Eric , Okuda, Darin T , Lehmann, Sylvain

Mayo Clinic

Multiple Sclerosis Journal | March 22, 2018 | Volume: 25 | Issue: 5 | Pages: 669-677

10.1177/1352458518767043 | PMID 29564952 Get It

Background: Younger age, male sex and presence of spinal cord lesion(s) increase the risk of conversion from radiologically isolated syndrome (RIS) to relapsing-remitting multiple sclerosis (RRMS). Elevated cerebrospinal fluid (CSF) chitinase-3-like protein 1 (CHI3L1) levels predict conversion from clinically isolated syndrome (CIS) to RRMS. Objective: To evaluate the prognostic value of CSF CHI3L1 in RIS patients for conversion to RRMS. Methods: We compared CSF CHI3L1 concentrations in RIS, CIS, RRMS and symptomatic controls (SCs). We analysed the influence of epidemiological, radiological and CSF parameters on the risk of clinical event. Results: A total of 211 patients (71 RIS, 48 CIS, 50 RRMS and 42 SC) were included. CSF CHI3L1 levels were lower in RIS than in RRMS and higher in RIS with positive CSF versus negative CSF and SC. The presence of at least one spinal cord lesion was the only independent predictor of faster conversion to RRMS. Association of high CSF CHI3L1 levels, positive CSF (presence of oligoclonal bands and/or an elevated IgG index) or four Barkhof criteria with any spinal cord lesion showed a tendency for reduced mean conversion time. Conclusion: CSF CHI3L1 correlates with positive CSF but is not an independent predictor of the risk of conversion from RIS to RRMS.
The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome
Gru, Alejandro A. , Pulitzer, Melissa , Guitart, Joan , Wood, Gary S. , Cerroni, Lorenzo , Pawade, Joya, Schaffer, András , Pincus, Laura B. , Tetzlaff, Michael T. , Scarisbrick, Julia , Mangold, Aaron R. , DiCaudo, David J. , Shinohara, Michi M. , Hong, Eric, Horton, Bethany J. , Mangold, A R , Gru, Alejandro , Shinohara, M M , Kim, Jinah , Battistella, Maxime , Kempf, Werner , Willemze, Rein , Querfeld, Christiane , Duvic, Madeleine , Porcu, Pierluigi , Kim, Youn H

Mayo Clinic

American Journal of Surgical Pathology | March 15, 2018 | Volume: 42 | Issue: 6 | Pages: 726-734

10.1097/pas.0000000000001041 | PMID 29543675 Get It

This pathology PILOT study aims to define the role and feasibility of centralized pathology review in a cohort of 75 patients from different centers in the United States and Europe using digital slide scanning. The pathologic material from 75 patients who had been diagnosed with mycosis fungoides/Sézary syndrome and were clinically staged as IIb or above was retrieved from 11 participating centers. Each pathology reviewer was provided with the pathologic diagnosis (by the referring pathologist), and the following list of histopathologic criteria (presence or absence) from the initial report: epidermotropism, folliculotropism (FT), large cell transformation, syringotropism, and granulomas. Patients with advance stage were selected for this study as this is a population where there is significant variability in the diagnosis of pathologic prognostic and predictive biomarkers. The slides were digitally scanned with an Aperio scanner and consensus review of cases occurred when major or minor discrepancies between the referral diagnosis and central pathology review occurred. Among the 75 cases, 70 (93.3%) had a final consensus diagnosis between the 3 central review pathologists. The overall agreement between the consensus review and the referring pathologist was 60%. The overall agreement was also higher between the reviewers and consensus review, compared with the referring pathologist and consensus. 65.3% of cases had some type of discrepancy (major or minor) between the outside and consensus review. Major discrepancies were seen in 34 of 73 cases (46.6%; 73 cases indicated a yes or no response). Minor discrepancies were seen in 32 of 75 (42.7%) of cases. Most of the major discrepancies were accounted by a difference in interpretation in the presence or absence of large cell transformation or FT. Most minor discrepancies were explained by a different interpretation in the expression of CD30. We found digital slide scanning to be a beneficial, reliable, and practical for a methodical approach to perform central pathology review in the context of a large clinical prospective study.
Hospitalizations for Cardiovascular Disease After Liver Transplantation in the United States†
Khurmi, Narjeet , Chang, Yu‐Hui, Steidley, D. Eric , Singer, Andrew L., Hewitt, Winston R. , Reddy, Kunam , Moss, Adyr A. , Mathur, Amit K.

Mayo Clinic

Liver Transplantation | March 15, 2018 | Volume: 24 | Issue: 10 | Pages: 1398-1410

10.1002/lt.25055 | PMID 29544033 Get It

Cardiovascular disease (CVD) is a leading cause of post–liver transplant death, and variable care patterns may affect outcomes. We aimed to describe epidemiology and outcomes of inpatient CVD care across US hospitals. Using a merged data set from the 2002‐2011 Nationwide Inpatient Sample and the American Hospital Association Annual Survey, we evaluated liver transplant patients admitted primarily with myocardial infarction (MI), stroke (cerebrovascular accident [CVA]), congestive heart failure (CHF), dysrhythmias, cardiac arrest (CA), or malignant hypertension. Patient‐level data include demographics, Charlson comorbidity index, and CVD diagnoses. Facility‐level variables included ownership status, payer‐mix, hospital resources, teaching status, and physician/nursing‐to‐bed ratios. We used generalized estimating equations to evaluate patient‐ and hospital‐level factors associated with mortality. There were 4763 hospitalizations that occurred in 153 facilities (transplant hospitals, n = 80). CVD hospitalizations increased overall by 115% over the decade (P < 0.01). CVA and MI declined over time (both P < 0.05), but CHF and dysrhythmia grew significantly (both P < 0.03); a total of 19% of hospitalizations were for multiple CVD diagnoses. Transplant hospitals had lower comorbidity patients (P < 0.001) and greater resource intensity including presence of cardiac intensive care unit, interventional radiology, operating rooms, teaching status, and nursing density (all P < 0.01). Transplant and nontransplant hospitals had similar unadjusted mortality (overall, 3.9%, P = 0.55; by diagnosis, all P > 0.07). Transplant hospitals had significantly longer overall length of stay, higher total costs, and more high‐cost hospitalizations (all P < 0.05). After risk adjustment, transplant hospitals were associated with higher mortality and high‐cost hospitalizations. In conclusion, CVD after liver transplant is evolving and responsible for growing rates of inpatient care. Transplant hospitals are associated with poor outcomes, even after risk adjustment for patient and hospital characteristics, which may be attributable to selective referral of certain patient phenotypes but could also be related to differences in quality of care. Further study is warranted.
A common data language for clinical research studies: the National Institute of Neurological Disorders and Stroke and American Academy for Cerebral Palsy and Developmental Medicine Cerebral Palsy Common Data Elements Version 1.0 recommendations
Schiariti, Verónica , Fowler, Eileen , Brandenburg, Joline E. , Levey, Eric, McIntyre, Sarah , Sukal‐Moulton, Theresa , Ramey, Sharon Landesman , Rose, Jessica , Sienko, Susan , Stashinko, Elaine, Feldman, Robin , Koenig, James I. , Feldman, Robin S , Koenig, James I , Vogtle, Laura K.

Mayo Clinic

Developmental Medicine & Child Neurology | March 15, 2018 | Volume: 60 | Issue: 10 | Pages: 976-986

10.1111/dmcn.13723 | PMID 29542813 Get It

To increase the efficiency and effectiveness of clinical research studies, cerebral palsy (CP) specific Common Data Elements (CDEs) were developed through a partnership between the National Institute of Neurological Disorders and Stroke (NINDS) and the American Academy of Cerebral Palsy and Developmental Medicine (AACPDM). International experts reviewed existing NINDS CDEs and tools used in studies of children and young people with CP. CDEs were compiled, subjected to internal review, and posted online for external public comment in September 2016. Guided by the International Classification of Functioning, Disability and Health framework, CDEs were categorized into six domains: (1) participant characteristics; (2) health, growth, and genetics; (3) neuroimaging; (4) neuromotor skills and functional assessments; (5) neurocognitive, social, and emotional assessments; and (6) engagement and quality of life. Version 1.0 of the NINDS/AACPDM CDEs for CP is publicly available on the NINDS CDE and AACPDM websites. Global use of CDEs for CP will standardize data collection, improve data quality, and facilitate comparisons across studies. Ongoing collaboration with international colleagues, industry, and people with CP and their families will provide meaningful feedback and updates as additional evidence is obtained. These CDEs are recommended for NINDS‐funded research for CP.What this paper adds This is the first comprehensive Common Data Elements (CDEs) for children and young people with CP for clinical research. The CDEs for children and young people with CP include common definitions, the standardization of case report forms, and measures. The CDE guides the standardization for data collection and outcome evaluation in all types of studies with children and young people with CP. The CDE ultimately improves data quality and data sharing.
Lightweight, compact, and high‐performance 3T MR system for imaging the brain and extremities
Foo, Thomas , Laskaris, E.T., Vermilyea, Mark, Xu, Minfeng , Thompson, Paul, Conte, Gene, Epps, Christopher Van, Immer, Christopher, Tan, Ek T. , Graziani, Dominic, Mathieu, Jean‐Baptise, Hardy, Christopher J., Schenck, John F., Fiveland, Eric, Stautner, Wolfgang , Ricci, Justin, Piel, Joseph E., Park, Keith, Hua, Yihe , Bai, Ye , Kagan, Alex, Stanley, David A. , Weavers, Paul T., Gray, Erin M. , Shu, Yunhong , Frick, Matthew A., Trzasko, Joshua D. , Foo, Thomas K F , Tan, Ek T , Gray, Erin, Trzasko, Joshua, Bernstein, Matt A , Thompson, Paul, Epps, Chris Van, Lee, Seung‐Kyun , Campeau, Norbert G. , Huston, John , Bernstein, Matt A.

Mayo Clinic

Magnetic Resonance in Medicine | March 15, 2018 | Volume: 80 | Issue: 5 | Pages: 2232-2245

10.1002/mrm.27175 | PMID 29536587 Get It

PurposeTo build and evaluate a small‐footprint, lightweight, high‐performance 3T MRI scanner for advanced brain imaging with image quality that is equal to or better than conventional whole‐body clinical 3T MRI scanners, while achieving substantial reductions in installation costs.MethodsA conduction‐cooled magnet was developed that uses less than 12 liters of liquid helium in a gas‐charged sealed system, and standard NbTi wire, and weighs approximately 2000 kg. A 42‐cm inner‐diameter gradient coil with asymmetric transverse axes was developed to provide patient access for head and extremity exams, while minimizing magnet‐gradient interactions that adversely affect image quality. The gradient coil was designed to achieve simultaneous operation of 80‐mT/m peak gradient amplitude at a slew rate of 700 T/m/s on each gradient axis using readily available 1‐MVA gradient drivers.ResultsIn a comparison of anatomical imaging in 16 patients using T2‐weighted 3D fluid‐attenuated inversion recovery (FLAIR) between the compact 3T and whole‐body 3T, image quality was assessed as equivalent to or better across several metrics. The ability to fully use a high slew rate of 700 T/m/s simultaneously with 80‐mT/m maximum gradient amplitude resulted in improvements in image quality across EPI, DWI, and anatomical imaging of the brain.ConclusionsThe compact 3T MRI system has been in continuous operation at the Mayo Clinic since March 2016. To date, over 200 patient studies have been completed, including 96 comparison studies with a clinical 3T whole‐body MRI. The increased gradient performance has reliably resulted in consistently improved image quality.
Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice
Li, Shuang , Robinson, Jennifer G. , Roger, Véronique L. , Goldberg, Anne C. , Wilson, Peter W.F. , Lee, L. Veronica, Elassal, Joseph, Wang, Tracy Y., Virani, Salim, Návar, Ann Marie , Peterson, Eric D. , Virani, Salim S. , Nanna, Michael G.

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | March 15, 2018 | Volume: 11 | Issue: 3 | Pages: No page available

10.1161/circoutcomes.117.004249 | PMID 29545393 Get It